My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 767

    1.

    The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study.

    Stein DS, Graham NM, Park LP, Hoover DR, Phair JP, Detels R, Ho M, Saah AJ.

    Ann Intern Med. 1994 Jul 15;121(2):100-8.PMID: 8017721 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

    Volberding PA, Lagakos SW, Grimes JM, Stein DS, Balfour HH Jr, Reichman RC, Bartlett JA, Hirsch MS, Phair JP, Mitsuyasu RT, et al.

    JAMA. 1994 Aug 10;272(6):437-42.PMID: 7913730 [PubMed - indexed for MEDLINE]Related articles

    3.

    Survival in HIV-infected patients who have received zidovudine: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Multicenter AIDS Cohort Study Group.

    Graham NM, Hoover DR, Park LP, Stein DS, Phair JP, Mellors JW, Detels R, Saah AJ.

    Ann Intern Med. 1996 Jun 15;124(12):1031-8.PMID: 8633816 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.

    Dorrucci M, Pezzotti P, Phillips AN, Alliegro MB, Rezza G.

    AIDS. 1997 Mar 15;11(4):461-7.PMID: 9084793 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.

    Chaisson RE, Keruly J, Richman DD, Moore RD.

    Arch Intern Med. 1992 Oct;152(10):2009-13.PMID: 1417373 [PubMed - indexed for MEDLINE]Related articles

    6.

    Predictors of mortality among HIV-infected women in Kigali, Rwanda.

    Lindan CP, Allen S, Serufilira A, Lifson AR, Van de Perre P, Chen-Rundle A, Batungwanayo J, Nsengumuremyi F, Bogaerts J, Hulley S.

    Ann Intern Med. 1992 Feb 15;116(4):320-8.PMID: 1733389 [PubMed - indexed for MEDLINE]Related articles

    7.

    Race, sex, drug use, and progression of human immunodeficiency virus disease.

    Chaisson RE, Keruly JC, Moore RD.

    N Engl J Med. 1995 Sep 21;333(12):751-6.PMID: 7643881 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.

    Justice AC, Stein DS, Fusco GP, Sherrill BH, Fusco JS, Danehower SC, Becker SL, Hansen NI, Graham NM; CHORUS Program Team.

    J Clin Epidemiol. 2004 Jan;57(1):89-97.PMID: 15019015 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients.

    Vella S, Giuliano M, Floridia M, Chiesi A, Tomino C, Seeber A, Barcherini S, Bucciardini R, Mariotti S.

    AIDS. 1995 Jan;9(1):51-6.PMID: 7893441 [PubMed - indexed for MEDLINE]Related articles

    10.

    A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.

    Volberding PA, Lagakos SW, Grimes JM, Stein DS, Rooney J, Meng TC, Fischl MA, Collier AC, Phair JP, Hirsch MS, et al.

    N Engl J Med. 1995 Aug 17;333(7):401-7.PMID: 7616988 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.

    Graham NM, Piantadosi S, Park LP, Phair JP, Rinaldo CR, Fahey JL.

    J Acquir Immune Defic Syndr. 1993 Nov;6(11):1258-66.PMID: 7901384 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.

    Gallant JE, Moore RD, Keruly J, Richman DD, Chaisson RE.

    J Infect Dis. 1995 Aug;172(2):346-52.PMID: 7622876 [PubMed - indexed for MEDLINE]Related articles

    13.

    Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.

    Wannamethee SG, Sirivichayakul S, Phillips AN, Ubolyam S, Ruxrungtham K, Hanvanich M, Phanuphak P.

    Int J Epidemiol. 1998 Apr;27(2):289-95.PMID: 9602412 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.

    Easterbrook PJ, Keruly JC, Creagh-Kirk T, Richman DD, Chaisson RE, Moore RD.

    JAMA. 1991 Nov 20;266(19):2713-8.PMID: 1942423 [PubMed - indexed for MEDLINE]Related articles

    15.

    Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.

    Molina JM, Ferchal F, Chevret S, Barateau V, Poirot C, Morinet F, Modai J.

    AIDS. 1994 Jan;8(1):27-33.PMID: 7912084 [PubMed - indexed for MEDLINE]Related articles

    16.

    Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

    Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS.

    JAMA. 1998 Feb 11;279(6):450-4.PMID: 9466638 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.

    Selwyn PA, Alcabes P, Hartel D, Buono D, Schoenbaum EE, Klein RS, Davenny K, Friedland GH.

    N Engl J Med. 1992 Dec 10;327(24):1697-703. Erratum in: N Engl J Med 1993 Mar 4;328(9):671. PMID: 1359411 [PubMed - indexed for MEDLINE]Related articles

    18.

    A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

    Hammer SM, Katzenstein DA, Hughes MD, Gundacker H, Schooley RT, Haubrich RH, Henry WK, Lederman MM, Phair JP, Niu M, Hirsch MS, Merigan TC.

    N Engl J Med. 1996 Oct 10;335(15):1081-90.PMID: 8813038 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Zidovudine use in AIDS-free HIV-1-seropositive homosexual men in the Multicenter AIDS Cohort Study (MACS), 1987-1989.

    Graham NM, Zeger SL, Kuo V, Jacobson LP, Vermund SH, Phair JP, Detels R, Rinaldo CR, Saah AJ.

    J Acquir Immune Defic Syndr. 1991;4(3):267-76.PMID: 1671411 [PubMed - indexed for MEDLINE]Related articles

    20.

    Didanosine compared with continued zidovudine therapy for HIV-infected patients with 200 to 500 CD4 cells/mm3. A double-blind, randomized, controlled trial. Canadian HIV Trials Network Protocol 002 Study Group.

    Montaner JS, Schechter MT, Rachlis A, Gill J, Beaulieu R, Tsoukas C, Raboud J, Cameron B, Salomon H, Dunkle L, Smaldone L, Wainberg MA.

    Ann Intern Med. 1995 Oct 15;123(8):561-71.PMID: 7677296 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity